🇺🇸 FDA
Patent

US 7371385

Method of treating immune pathologies with low dose estrogen

granted A61KA61K31/56A61K31/565

Quick answer

US patent 7371385 (Method of treating immune pathologies with low dose estrogen) held by Government of the United states of America dba The Department of Veterans Affairs expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Government of the United states of America dba The Department of Veterans Affairs
Grant date
Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/56, A61K31/565, A61K31/566, A61K38/191